サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1575762

細胞増殖の世界市場：2024年～2031年

Global Cell Expansion Market - 2024-2031

出版日
ページ情報
英文 186 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
細胞増殖の世界市場：2024年～2031年
出版日: 2024年10月22日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポート概要

細胞増殖の世界市場は、2023年に200億米ドルに達し、2031年には550億米ドルに達すると予測され、予測期間2024-2031年のCAGRは15.3%で成長する見込みです。

細胞増殖とは、分離した細胞を何世代にもわたって培養し、患者の再生反応に必要な細胞数を得るプロセスです。これには、閉鎖培養容器での連続継代と、代謝物を除去し栄養分を供給するための培養液の使用が含まれます。

さらに、細胞増殖はバイオテクノロジーや再生医療において重要なプロセスであり、治療応用のために特定の細胞タイプの量を増やすことを目的としています。幹細胞や免疫細胞など、大量の細胞を必要とする細胞ベースの治療法の開発には欠かせないです。細胞増殖の意義は、がん免疫療法、組織工学、再生医療のための機能的細胞の生産にあります。

市場力学：

促進要因と阻害要因

慢性疾患の増加

世界の細胞増殖市場は、がん、糖尿病、自己免疫疾患などの慢性疾患の増加により拡大しています。このため、再生医療、細胞ベース治療、個別化治療などの高度な治療に対する需要が高まっています。これらの治療法の開発には細胞の拡大が不可欠であり、ヘルスケアプロバイダーや研究者は、効果的な治療オプションに対する世界のニーズに応えるため、革新的なソリューションを模索しています。

例えば、Institute for Health Metrics and Evaluationによると、2023年、糖尿病は全世界で5億人以上が罹患し、老若男女が影響を受ける。この数は今後30年間で倍増し、13億人に達すると予測されており、どの国でも増加傾向にあります。世界の有病率は6.1％で、糖尿病は死亡と身体障害の主要原因のトップ10に入る。北アフリカと中東の有病率は9.3％と最も高く、2050年には16.8％まで上昇すると予測されています。

細胞生物学に関する倫理的懸念

細胞生物学における倫理的懸念は、細胞増殖市場を制限しています。ヒト胚の破壊を伴う胚性幹細胞の使用は、多くの国で規制の対象となっています。成体幹細胞は倫理的な選択肢の一つであるが、侵襲的な手技を伴うことが多く、患者の同意や安全性への懸念があります。遺伝子組み換え細胞は、患者や環境に潜在的なリスクをもたらします。こうした倫理的な懸念が、細胞増殖市場の成長を妨げています。

市場セグメンテーション

世界の細胞増殖市場は、製品タイプ、細胞タイプ、用途、エンドユーザー、地域によって区分されます。

製品タイプ別では、器具が細胞増殖市場シェアの約41.3%を占めています。

製品タイプ別では、器具が約41.3%を占める。機器は細胞増殖において極めて重要であり、治療や調査目的のために制御された増殖を可能にします。自動バイオリアクター、セルカウンター、遠心分離機、インキュベーターは、細胞増殖中の最適条件を維持し、一貫性、拡張性、効率を確保します。これらの装置は再生医療、免疫療法、組織工学に不可欠です。高度な装置は、細胞の生存率と収量を向上させ、汚染リスクを低減し、臨床使用のための高品質の細胞を生産します。

例えば、2024年9月、10x Genomics, Inc.は、限られた予算で高品質のデータを求める研究者のために設計された新しいシングルセル装置、Chromium Xoを発売しました。この手頃な価格の高性能シングルセル解析装置は、同社のChromiumシングルセル装置の一部です。

市場地域別シェア

北米は予測期間を通じて市場シェア全体の約38.4%を占めると予測される

北米は、がん罹患率の上昇、政府助成金の増加、幹細胞治療に関する調査、先進的治療法に対する意識の高まりなどから、予測期間を通じて市場全体の約38.4%を占めると推定されます。

例えば、2024年10月、個別化（自己）細胞療法を開発する非公開バイオテクノロジー企業であるアスペン・ニューロサイエンス社は、トーリーパインズの本社近くにサンディエゴの拠点を拡大し、人工多能性幹細胞（iPSC）由来の細胞療法をGMPで製造するための22,000平方フィートの施設を新設すると発表しました。

さらに2024年8月、プルリ社は独自の3D細胞増殖技術を用いた免疫細胞の新しい拡大方法に関する米国特許を取得しました。この技術は、人体内の免疫細胞の自然なリンパ節のような環境を模倣するもので、効率的な細胞増殖に必要な条件をスケールと品質で提供します。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 慢性疾患の増加
      • デバイスの進歩
    • 抑制要因
      • 細胞生物学に関する倫理的懸念
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 特許分析
  • PESTLE分析
  • SWOT分析
  • DMIオピニオン

第6章 製品タイプ別

  • 自動細胞増殖システム
  • 機器
  • 消耗品
  • バイオリアクター

第7章 細胞タイプ別

  • 動物細胞
  • ヒト細胞
  • 幹細胞（SC）
  • 成体幹細胞
  • その他

第8章 用途別

  • 再生医療と幹細胞研究
  • 臨床研究
  • ワクチン製造
  • その他

第9章 エンドユーザー別

  • バイオ医薬品・バイオテクノロジー企業
  • 研究機関
  • 病院
  • 診断研究所
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Thermo Fisher Scientific, Inc
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Merck KGaA
  • Becton, Dickinson and Company
  • GE Healthcare
  • Terumo BCT
  • Beckman Coulter Inc
  • Miltenyi Biotec
  • Stemcell Technologies, Inc.
  • Takara Bio Inc.
  • Lnza Group LTD（*LIST NOT EXHAUSTIVE）

第13章 付録

目次
Product Code: BT2695

Report Overview

Global Cell Expansion Market reached US$ 20 billion in 2023 and is expected to reach US$ 55 billion by 2031, growing at a CAGR of 15.3% during the forecast period 2024-2031.

Cell expansion is the process of culturing isolated cells for multiple generations to achieve the desired number of cells for a regenerative response in a patient. This involves serial passages in closed culture vessels and the use of culture medium to remove metabolites and provide nutrients.

Moreover, cell expansion is a crucial process in biotechnology and regenerative medicine, aiming to increase the quantity of specific cell types for therapeutic applications. It is essential for developing cell-based therapies, such as stem cells and immune cells, which require large numbers of cells. Cell expansion's significance lies in producing functional cells for cancer immunotherapy, tissue engineering, and regenerative medicine.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of chronic diseases

The global cell expansion market is expanding due to the rise in chronic diseases like cancer, diabetes, and autoimmune disorders. This has led to a demand for advanced therapies like regenerative medicine, cell-based therapies, and personalized treatments. Cell expansion is crucial for developing these treatments, and healthcare providers and researchers are seeking innovative solutions to meet the global need for effective treatment options.

For instance, in 2023, according to Institute for Health Metrics and Evaluation, Diabetes affects over half a billion people globally, affecting men, women, and children of all ages. The number is projected to double to 1.3 billion in the next 30 years, with every country experiencing an increase. The global prevalence rate is 6.1%, making diabetes one of the top 10 leading causes of death and disability. North Africa and the Middle East have the highest rate at 9.3%, which is projected to rise to 16.8% by 2050.

Ethical concern related to cell biology

Ethical concerns in cell biology are limiting the cell expansion market. The use of embryonic stem cells, which involve human embryo destruction, has led to restrictions in many countries. Adult stem cells, an ethical alternative, often involve invasive procedures, raising concerns about patient consent and safety. Genetically modified cells pose potential risks to patients and the environment. These ethical concerns are hindering the growth of the cell expansion market.

Market Segment Analysis

The global cell expansion market is segmented based on product type, cell type, application, end user and region.

The instruments from the product type segment accounted for approximately 41.3% of the cell expansion market share

The instruments from the product type segment accounted for approximately 41.3%. Instruments are crucial in cell expansion, enabling controlled growth and multiplication for therapeutic and research purposes. Automated bioreactors, cell counters, centrifuges, and incubators maintain optimal conditions during cell culture, ensuring consistency, scalability, and efficiency. These devices are essential for regenerative medicine, immunotherapy, and tissue engineering. Advanced instrumentation improves cell viability and yield reduces contamination risks, and produces high-quality cells for clinical use.

For instance, in September 2024, 10x Genomics, Inc. launched Chromium Xo, a new single cell instrument designed for researchers seeking high-quality data on limited budgets. This affordable entry point into routine, high-performance single cell analysis is part of its fleet of Chromium single cell instruments.

Market Geographical Share

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to rising cancer incidence, increased government funding, research on stem cell therapies, and increased awareness of advanced treatment methods.

For instance, in October 2024, Aspen Neuroscience, Inc., a private biotechnology company developing personalized (autologous) cell therapies, announced the expansion of its San Diego footprint near its headquarters in Torrey Pines, with a new 22,000 square foot facility for GMP manufacturing of induced pluripotent stem cell (iPSC)-derived cell therapies.

Moreover, in August 2024, Pluri Inc has been granted a US patent for a new method for expanding immune cells using proprietary 3D cell expansion technology. This technology mimics the natural lymph node-like environment of immune cells within the human body, providing cells with the necessary conditions for efficient expansion at scale and quality.

Market Segmentation

By Product Type

Automated Cell Expansion Systems

Instruments

Cell Expansion Supporting Equipment

Cell Counters

Flow Cytometers

Centrifuges

Other Supporting Equipment

Others

Consumables

Reagents

Media

Disposables

Tissue Culture Flasks

Others

Bioreactors

Microcarrier Bioreactors

Microcarrier-based anchorage-dependent bioreactors

Suspension-based anchorage-independent bioreactors

Perfusion/Hollow Fibre Bioreactors

By Cell Type

Animal Cells

Human Cells

Stem Cells (SCs)

Adult Stem Cells

Others

By Application

Regenerative Medicine and Stem Cell Research

Clinical Studies

Vaccine Production

Others

By End User

Biopharmaceutical & Biotechnology Companies

Research Institutes

Hospitals

Diagnostic Laboratories

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Competitive Landscape

The major global players in the market include Thermo Fisher Scientific, Inc, Merck KGaA, Becton, Dickinson and Company, GE Healthcare, Terumo BCT, Beckman Coulter Inc, Miltenyi Biotec, Stemcell Technologies, Inc., Takara Bio Inc., Lnza Group LTD among others.

Key Developments

In August 2024, HC Corporation Biomedical Division showcased a prototype of its new cell expansion system, LiCellGrow, at the ISCT Europe 2024 Regional Meeting in Gothenburg, Sweden. LiCellGrow allows pharmaceutical companies to visualize real-time metabolic changes in cells and automatically adjust cell culture conditions for optimal growth. It aims to increase the availability of cell and gene therapy products by accelerating the manufacturing of specific cells needed for these therapies.

In March 2024, Getinge has partnered with the bioprocessing company CellRev in the development of a continuous cell processing platform called Livit ACE (Adherent Cell Expansion). The solution is a breakthrough within allogenic cell therapy manufacturing.

Why Purchase the Report?

To visualize the global cell expansion market segmentation based on product type, cell type, application, end user and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the cell expansion market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global cell expansion market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Cell Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the prevalence of chronic diseases
      • 4.1.1.2. Rise in the advancements of devices
    • 4.1.2. Restraints
      • 4.1.2.1. Ethical concern related to cell biology
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Patent Analysis
  • 5.6. PESTLE Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Automated Cell Expansion Systems*
    • 6.2.1. Introduction
  • 6.3. Instruments
  • 6.4. Consumables
  • 6.5. Bioreactors

7. By Cell Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
  • 7.2. Market Attractiveness Index, By Cell Type
  • 7.3. Animal Cells*
    • 7.3.1. Introduction
    • 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.4. Human Cells
  • 7.5. Stem Cells (SCs)
  • 7.6. Adult Stem Cells
  • 7.7. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.2. Market Attractiveness Index, By Application
  • 8.3. Regenerative Medicine and Stem Cell Research*
    • 8.3.1. Introduction
    • 8.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.4. Clinical Studies
  • 8.5. Vaccine Production
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Biopharmaceutical & Biotechnology Companies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Research Institutes
  • 9.4. Hospitals
  • 9.5. Diagnostic Laboratories
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. UK
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Thermo Fisher Scientific, Inc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Merck KGaA
  • 12.3. Becton, Dickinson and Company
  • 12.4. GE Healthcare
  • 12.5. Terumo BCT
  • 12.6. Beckman Coulter Inc
  • 12.7. Miltenyi Biotec
  • 12.8. Stemcell Technologies, Inc.
  • 12.9. Takara Bio Inc.
  • 12.10. Lnza Group LTD (*LIST NOT EXHAUSTIVE)

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us